SCHEMBL7104136

SCHEMBL7104136

CC(C)(C)OC(=O)NC(C(=O)NCCCc1ccccc1)C(=O)NCCCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
KMT2A Q03164 1/20 0.58
CTSK P43235 4/20 0.56
CTSS P25774 3/20 0.56
POLB P06746 1/20 0.55
CNR1 P21554 1/20 0.53
KDM4A O75164 1/20 0.52
CTSL P07711 1/20 0.52
CTSB P07858 1/20 0.52
MMP8 P22894 2/20 0.51
AKT1 P31749 1/20 0.51
MMP1 P03956 1/20 0.50
MMP3 P08254 1/20 0.50
MMP9 P14780 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
EPHX2 P34913 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7103984 0.92 CTSK (0.60) CTSKCTSSCTSLCTSBAKT1
SCHEMBL12294700 0.89 KMT2A (0.60) CYP2D6CYP2C9CYP2C19KMT2ACTSK
SCHEMBL4583683 0.85 POLB (0.65) CYP2D6CYP2C9CYP2C19KMT2ACTSK
SCHEMBL7102367 0.84 ATM (0.59) CTSKCTSSCTSLCTSBAKT1
SCHEMBL22822796 0.81 CTSS (0.63) CTSKCTSSCNR1CTSLCTSB
SCHEMBL4961185 0.81 SIGMAR1 (0.62) KMT2APOLBMMP8MMP1MMP3
SCHEMBL7102658 0.81 CTSK (0.49) CTSKCTSSCTSLCTSBAKT1
SCHEMBL12333754 0.80 SIGMAR1 (0.58) CYP2D6CYP2C9CYP2C19KMT2ACTSK
SCHEMBL5468072 0.80 NPSR1 (0.61) KMT2APOLBMMP8MMP1MMP3
SCHEMBL22102023 0.80 NPSR1 (0.61) KMT2APOLBMMP8MMP1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140818-B1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMA INC (US) 2003-09-10 EP disclosed
US-6329550-B1 FOR THERAPY OF EMPHYSEMA, OSTEOPOROSIS, RHEUMATOID ARTHRITIS AND NEOPLASTIC DISEASES AVENTIS PHARMACEUTICALS INC. 2001-12-11 US disclosed
EP-1140818-A1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE Aventis Pharmaceuticals Inc. (US) 2001-10-10 EP disclosed
WO-2000040552-A1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMACEUTICALS INC. (US) 2000-07-13 WO disclosed